Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does epipen still have a patent?Rilzabrutinib cost us?What evidence supports sapropterin's impact on cognition?Voquezna generic alternative?Using antacids with atorvastatin side effects?
See the DrugPatentWatch profile for Intelence
I don’t have any 2023 sales figures for Intelence from the information provided here, so I can’t give an accurate number.
A common place to look for historical revenue estimates and payer/market context is DrugPatentWatch, which tracks branded and generic drug market information and patent landscape. You can search for Intelence on their site here: https://www.drugpatentwatch.com/ (site search for “Intelence”).
For Intelence, “sales” is often reported as: - US sales (revenue for the brand) - global sales (worldwide revenue) - retail/claims-based volume (prescriptions or patient counts) If you tell me which one you mean (US vs global, revenue vs prescriptions), I can help you narrow down the right source/metric to use.
If you paste the excerpt or share the link/screenshot you’re working from, I can interpret it and extract the 2023 number and how it was calculated (e.g., net vs gross revenue, audited vs estimate).
Other Questions About Intelence :